3D printing is rapidly changing the future of pharmaceutical manufacturing by creating new opportunities in formulation design, drug delivery, and patient focused therapies. Adare’s Giuseppe De Franza, Director, Research and Development Italy, will discuss how 3D screen printing is helping reshape traditional pharmaceutical processes and enabling innovative solutions for complex therapeutic challenges. This webinar will explore the advantages of 3D printing compared to conventional manufacturing methods, including the ability to develop complex drug release profiles and smart drug delivery systems tailored to patient needs. Real world examples featuring Carbidopa/Levodopa applications and gummy delivery systems will highlight how advanced manufacturing technologies are driving flexibility, innovation, and improved patient outcomes.